• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1993 - 1997年新加坡的癌症生存率

Cancer survival in Singapore, 1993-1997.

作者信息

Chia K S

机构信息

Singapore Cancer Registry, Centre for Molecular Epidemiology, c/o Department of Community, Occupational and Family Medicine, National University of Singapore, Singapore.

出版信息

IARC Sci Publ. 2011(162):183-98.

PMID:21675423
Abstract

The Singapore cancer registry is a national registry established in 1968. Cancer registration is done by passive methods. The registry contributed survival data on 45 cancer sites or types registered during 1993-1997. Data on 34 cancers registered during 1968-1997 were utilized for survival trend by period and cohort approaches. Follow-up was done by passive methods, with median follow-up ranging between 2-72 months for different cancers. The proportion with histologically verified diagnosis for various cancers ranged between 27-100%; death certificates only (DCOs) comprised 0-7%; 76-100% of total registered cases were included for the survival analysis. The top-ranking cancers on 5-year age-standardized relative survival rates were nonmelanoma skin (96%), thyroid (90%), testis (88%), corpus uteri (77%), breast (74%), Hodgkin lymphoma (73%) and penis (70%). Five-year relative survival by age group showed either a decreasing trend with increasing age groups or was fluctuating. Localized stage of disease ranged between 18-65% for various cancers and survival decreased with increasing extent of disease. Period survival closely predicted survival experience of cancers diagnosed in that period, and an increasing trend in period survival over different periods indicated an improved prognosis for cancers diagnosed in those calendar periods.

摘要

新加坡癌症登记处是一个于1968年设立的国家登记机构。癌症登记通过被动方式进行。该登记处提供了1993 - 1997年期间登记的45种癌症部位或类型的生存数据。利用1968 - 1997年期间登记的34种癌症的数据,采用时期和队列方法分析生存趋势。随访通过被动方式进行,不同癌症的中位随访时间在2 - 72个月之间。各种癌症经组织学确诊的比例在27% - 100%之间;仅依据死亡证明(DCOs)的比例为0% - 7%;生存分析纳入了76% - 100%的登记病例总数。按5年年龄标准化相对生存率排名靠前的癌症有非黑色素瘤皮肤癌(96%)、甲状腺癌(90%)、睾丸癌(88%)、子宫体癌(77%)、乳腺癌(74%)、霍奇金淋巴瘤(73%)和阴茎癌(70%)。按年龄组划分的5年相对生存率显示,要么随年龄组增加呈下降趋势,要么呈波动状态。各种癌症的疾病局限期在18% - 65%之间,且生存率随疾病范围扩大而降低。时期生存率能很好地预测该时期诊断出的癌症患者的生存情况,不同时期时期生存率的上升趋势表明这些日历时期诊断出的癌症患者预后有所改善。

相似文献

1
Cancer survival in Singapore, 1993-1997.1993 - 1997年新加坡的癌症生存率
IARC Sci Publ. 2011(162):183-98.
2
Cancer survival in Incheon, Republic of Korea, 1997-2001.1997 - 2001年韩国仁川的癌症生存率
IARC Sci Publ. 2011(162):163-9.
3
Cancer survival in Busan, Republic of Korea, 1996-2001.1996 - 2001年韩国釜山的癌症生存率
IARC Sci Publ. 2011(162):155-62.
4
Cancer survival in Seoul, Republic of Korea, 1993-1997.1993 - 1997年韩国首尔的癌症生存率
IARC Sci Publ. 2011(162):171-8.
5
Cancer survival in Shanghai, China, 1992-1995.1992 - 1995年中国上海的癌症生存率
IARC Sci Publ. 2011(162):55-68.
6
Cancer survival in Cuba, 1994-1995.1994 - 1995年古巴的癌症生存率
IARC Sci Publ. 2011(162):89-95.
7
Cancer survival in Qidong, China, 1992-2000.1992 - 2000年中国启东的癌症生存率
IARC Sci Publ. 2011(162):43-53.
8
Cancer survival in Tianjin, China, 1991-1999.1991 - 1999年中国天津的癌症生存率
IARC Sci Publ. 2011(162):69-84.
9
Cancer survival in Lampang, Thailand, 1990-2000.泰国南邦府1990 - 2000年癌症生存率。
IARC Sci Publ. 2011(162):217-26.
10
Cancer survival in Songkhla, Thailand, 1990-1999.泰国宋卡1990 - 1999年的癌症生存率。
IARC Sci Publ. 2011(162):227-35.

引用本文的文献

1
Five-year survival rate of kidney cancer (localized renal cell carcinoma) in the Asia: A systematic review and meta-analysis.亚洲肾癌(局限性肾细胞癌)的五年生存率:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Aug 22;104(34):e43867. doi: 10.1097/MD.0000000000043867.
2
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.亚洲国家肝细胞癌的生存率:一项系统评价与荟萃分析。
EXCLI J. 2020 Jan 13;19:108-130. doi: 10.17179/excli2019-1842. eCollection 2020.
3
Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis.
亚洲国家前列腺癌的生存率:一项系统评价与荟萃分析。
Ann Glob Health. 2020 Jan 2;86(1):2. doi: 10.5334/aogh.2607.
4
A cross sectional study on the motivators for Asian women to attend opportunistic mammography screening in a private hospital in Malaysia: the MyMammo study.一项关于马来西亚一家私立医院中亚洲女性参加机会性乳腺钼靶筛查动机的横断面研究:MyMammo研究
BMC Public Health. 2015 Jun 12;15:548. doi: 10.1186/s12889-015-1892-1.